Navigation Links
CSL Biotherapies initiates shipments of its seasonal influenza vaccine to U.S. customers
Date:8/6/2013

KING OF PRUSSIA, Pa., Aug. 6, 2013 /PRNewswire/ -- CSL Biotherapies, Inc. announced today that shipment of its seasonal influenza vaccine for the 2013-2014 season has started.

"Given the magnitude of influenza burden in the U.S. and the unpredictability of seasonal outbreaks, timely delivery of flu vaccines is more critical now than ever before," said Dr. Marie Mazur, Head of Worldwide Commercial Operations, Influenza. "CSL Biotherapies is committed to addressing this public health need by consistently delivering its influenza vaccine early to the healthcare providers in the United States."

CSL Biotherapies will ship approximately 11 million doses of the seasonal flu vaccine to the United States for the upcoming season. Shipment will comprise multi-dose and pre-filled syringe presentations.

About CSL Biotherapies, Inc.
CSL Biotherapies, Inc., located in King of Prussia, PA, is the U.S. headquarters of bioCSL. Parent company CSL Limited has manufactured influenza vaccine in its Melbourne, Australia facility since 1968. CSL Limited has made a $60 million (U.S.D.) investment in plant and equipment to double capacity at its Melbourne facility, making it one of the largest vaccine manufacturing facilities in the world.  CSL-branded influenza vaccines are approved in 28 countries.

At bioCSL, delivering vaccines is our mission, protecting lives our passion. The CSL Group, which also includes CSL Research & Development, CSL Plasma, and CSL Behring, has more than 11,000 employees globally and operates in 26 countries around the world. 

Media Contact:
Sheila Burke
610-878-4209


'/>"/>
SOURCE CSL Biotherapies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
2. CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
3. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
4. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
5. Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers
6. MAQUET Initiates Class I Recall of the FLOW-i Anesthesia System
7. Stryker Initiates Voluntary Product Recall of Modular-Neck Stems
8. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
9. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
10. Empire Asset Management Co. Initiates Coverage on Transcept Pharmaceuticals Inc., (NASDAQ: TSPT)
11. Karyopharm Therapeutics Initiates Two Phase 1 Trials with Oral KPT-330, the First Selective Inhibitor of Nuclear Export (SINE), in Patients with Advanced Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... it comes to welcoming our new robot overlords, InformationWeek editor ... red carpet. Healthcare is one of the major ... our human sphere. With healthcare concerns top of mind in ... new technologies to help with old problems. That,s where robots ... to increase from $1.7 billion now to $3.7 billion by ...
(Date:7/23/2014)... MEETING, Pa. , July 23, 2014 ... INO) today announced successful results from its ... VGX-3100 in women with biopsy-proven cervical intraepithelial ... (HPV) types 16 or 18. Treatment with ... regression of CIN2/3 to CIN1 or no ...
(Date:7/23/2014)... LOS ANGELES , July 23, 2014  Researchers ... supplementing with calcium elevates calcium levels too ... stones, among other health problems. Women close ... calcium and vitamin D to prevent diseases such as ... "I would recommend that women determine how much calcium ...
Breaking Medicine Technology:Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Women Taking Too Much Calcium Create Health Risk 2
... Nov. 8, 2010 GenVec, Inc. (Nasdaq: GNVC ) ... 30, 2010.   GenVec reported a net loss of ... 30, 2010 compared to a net loss of $3.6 million ($0.04 ... months ended September 30, 2010, GenVec,s net loss was $11.3 million ...
... 8, 2010 XStor Medical Systems, Inc. announces the ... quality management system certification is a key step in ... globally. "XStor,s software products are designed under ... codifies our ability to deliver safe & effective solutions. ...
Cached Medicine Technology:GenVec Reports Third Quarter 2010 Financial Results 2GenVec Reports Third Quarter 2010 Financial Results 3GenVec Reports Third Quarter 2010 Financial Results 4GenVec Reports Third Quarter 2010 Financial Results 5
(Date:7/23/2014)... Recently, iFitDress.com, a professional company of women’s dresses ... vintage party dresses . Aside from that, it has ... is up to 63% off. , “We are excited to ... items are all manufactured by trustworthy and experienced workers in ... 30; it is great to provide such a great opportunity ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 A new ... a power morcellator ( http://www.injurybeacon.com/power-morcellator/ ) during minimally ... cancers throughout a woman’s body, Bernstein Liebhard LLP reports. ... the Journal of the American Medical Association, looked at ... morcellator at 500 U.S. hospitals from 2006 to 2012. ...
(Date:7/23/2014)... Steven Reinberg HealthDay Reporter ... obese and overweight American children and teens look in ... U.S. health officials reported Wednesday. "Being overweight or ... high blood pressure, high cholesterol and diabetes," said lead ... Centers for Disease Control and Prevention,s National Center for ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Home ... in-home care for seniors, is proud to announce the ... featuring experts in a wide range of health and ... social worker and award-winning author Nancy Kriseman, and will ... ways to prevent burnout by becoming more self-aware. In ...
(Date:7/23/2014)... body of research suggesting a safe and effective ... breast cancer, with fewer detrimental side effects and ... The study will be published in final format ... and Endocrinology . , Breast cancer is the ... United States. Approximately 70% of breast cancers are ...
Breaking Medicine News(10 mins):Health News:Cheap 2014 Vintage Party Dresses From Professional Supplier iFitDress.com 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 4Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 2Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 3Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5
... News) -- Older women who take nonsteroidal anti-inflammatory drugs -- ... lower risk of death from colorectal cancer than women who ... Women who reported using these drugs, called NSAIDs, at the ... roughly 30 percent lower rate of death from colorectal cancer ...
... OCTOBER 24, 2011) Heavy alcohol consumption may be ... while higher BMI and increased consumption of black tea ... deadly disease. In three separate studies presented at CHEST ... of Chest Physicians (ACCP), heavy alcohol consumption was related ...
... safe and effective therapy, according to a new long-term ... co-hosted by the Heart and Stroke Foundation and the ... Ottawa Heart Institute heart transplant program revealed results from ... transplant patients. Mean age at transplant was 49 13 ...
... Postmenopausal women who reported having used nonsteroidal anti-inflammatory drugs ... enrollment in the Women,s Health Initiative study had a ... women who reported no use of these drugs at ... International Conference on Frontiers in Cancer Prevention Research, held ...
... October 23, 2011 -- A new study conducted in an ... called "lazy eye," can be achieved in many older children, ... games along with standard amblyopia treatment. Today at the 115th ... Ghosh will report on the approaches that allowed about a ...
... rehabilitation boosts longevity, especially in patients with the lowest ... Cardiovascular Congress 2011, co-hosted by the Heart and Stroke ... benefits to cardiac rehabilitation, regardless of how fit ... cardiac surgery resident and PhD candidate at the University ...
Cached Medicine News:Health News:Can NSAIDs Cut Colorectal Cancer Deaths in Older Women? 2Health News:Heavy alcohol consumption linked to lung cancer 2Health News:Heart transplant surgery safe and effective: A Canadian retrospective spanning 3 decades 2Health News:Heart transplant surgery safe and effective: A Canadian retrospective spanning 3 decades 3Health News:NSAID use associated with lower colorectal cancer mortality rates among postmenopausal women 2Health News:Video games used in new treatment that may fix 'lazy eye' in older children 2Health News:Rehab helps heart patients live longer -- but they have to show up 2Health News:Rehab helps heart patients live longer -- but they have to show up 3
Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
Nucleus manipulator used during phacoemulsification. Used to break-up the nuclues within the capsular bag during two-handed phaco techniques. Blunt round tip, angled 40 degrees, 11mm from tip. Tip an...
... original Magstim design the new Magstim 200 ... of knowledge and expertise gathered in both ... an innovative design that will help further ... system of preferred choice. Ergonomic modular ...
... a surgical approach to glaucoma management that ... The ciliary body (which produces aqueous humour) ... anterior or posterior segment, through the endoscope ... easily and accurately identified utilizing endoscopy. This ...
Medicine Products: